No abstract

received chemotherapy only (68.3%). We observed a statistically significant difference between the two modalities in white patients, patients aged between 40 to 59 years, tumors arising in sigmoid colon or rectum, patients with elevated CEA levels, and those with metastasis to the lungs only or both lung and liver. Conclusions: Combining pulmonary metastasectomy with chemotherapy in CRC patients with pulmonary and extrapulmonary metastases shows higher 1-year relative survival rates when compared to using chemotherapy alone. Legal entity responsible for the study: Inas Uthman Funding: Has not received any funding Disclosure: All authors have declared no conflicts of interest.

No abstract

No abstract

No abstract